Table 2.
Final pathology | n (%) |
---|---|
DCIS/invasive carcinoma | 108 (45.8) |
DCIS | 95 (40.3) |
Invasive carcinoma | 13 (5.5) |
High-risk lesion | 82 (34.7) |
ADH-BD | 10 (4.2) |
ADH | 33 (14.0) |
ADH and lobular neoplasia | 18 (7.6) |
Lobular neoplasia | 21 (8.9) |
Benign pathology | 46 (19.5) |
CNB core needle biopsy, ADH-BD atypical ductal hyperplasia bordering on ductal carcinoma in situ, ADH atypical ductal hyperplasia